On March 13, 2018NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, reported that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the month of March and April 2018 (Press release, NantKwest, MAR 13, 2018, http://ir.nantkwest.com/phoenix.zhtml?c=254059&p=RssLanding&cat=news&id=2337947 [SID1234524736]). The presentations and one-on-one discussions will feature a science and business overview, along with a clinical update provided by company management.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:
Event: Roth Capital 30th Annual Investment Conference
Date/Time: Tuesday, March 13, 2018, one-on-one meetings
Location: Laguna Niguel, CA

Event: Cowen & Company 38th Annual Healthcare Conference
Date/Time: Wednesday, March 14, 2018, one-on-one meetings
Location: Boston, MA

Event: Oppenheimer & Company 28th Annual Healthcare Conference
Date/Time: Tuesday, March 20, 2018, one-on-one meetings
Location: New York, NY

Event: Needham & Company 17th Annual Healthcare Conference
Date/Time: Wednesday, March 28, 2018, presentation at 12:45pm
Location: New York, NY

Event: Hanson Wade Innate Killer Summit
Date/Time: Thursday, March 29, 2018, presentation at 12:50pm
Location: New York, NY

Event: Jefferies IO Cell Therapy Investment Conference
Date/Time: Tuesday, April 3, 2018, presentation at 11:40am
Location: Boston, MA